Compa ss
1st half-year 2026

![]()
1st half-year 2026

ADC The oncology landscape is changing. ADCs are dominating research, development, and clinical breakthroughs. World ADC London brings together the experts at the forefront of this evolution, scientists, clinicians, and industry leaders driving the ADC revolution.
World ADC London (23–26 February 2026 | London, UK) is THE week for anyone working in, or interested in learning about, bioconjugates and the rapidly advancing ADC landscape. This year’s agenda delivers five comprehensive streams spanning discovery, preclinical and translational research, clinical insights, process and analytical development, and

GREETING As the Program Director, I’m proud to present an agenda infused with global innovation across ADC design, development, and production. Join us at Europe’s definitive ADC forum to harness next-generation advancements and maximise therapeutic potential.”
Ewen Ward
Program Director - World ADC
Hanson Wade

23–26 February, 2026
London UK
manufacturing and supply chain. Attendees can expect cutting-edge updates in ADC design, development, and production, along with forward-looking strategies to help overcome patient resistance and accelerate ADCs into earlier-line oncology settings.
Whether you’re new to ADCs or a seasoned expert, the meeting allows you to tailor your experience across both essential foundations and the latest scientific and technological trends. You’ll gain practical technical insights and industryled content designed to strengthen your daily work, support decision-making, and advance your ADC expertise in a fastmoving global environment.
As more than 800 ADC decision-makers from across Europe and beyond come together at the first major ADC touchpoint of 2026, you’ll have the chance to participate in both structured networking and informal social activities running alongside the scientific programme. Highlights include Comprehensive One-on-One Partnering™, a scientific poster session, collaborative lunch-and-learn discussions, and an evening drinks reception designed
DATES
23-26 February, 2026
VENUE INFORMATION
London, UK at Excel London, Royal Victoria Dock, 1 Western Gateway, London, E16 1XL
2025 FIGURES
800+ Industry Attendees
110+ Global Speaker Faculty 5 Tracks of End-to-End ADC Content
PROGRAM HIGHLIGHTS
First-Time Presenting Companies Adcoris Biopharma, ALX Oncology, Salubris Bio & More | Brand-New ADC Regulator, Clinician & Investor Speaker Representation | Differentiated ADC Payload & Design Content Front & Centre | Global ADC Speaker Faculty from Europe, North America & Asia
www.worldadc-europe.com
to spark new ideas, partnerships, and collaborations.
Don’t miss trailblazing solutions to resistance mechanisms, new thinking on accelerating ADCs into earlier lines of care, and the opportunity to connect with the leaders shaping the future of this transformative therapeutic modality.












BIO-EUROPE SPRING BIO-Europe Spring connects Europe’s top innovation centers with the global life sciences industry to cultivate thriving, strategic partnerships.
Access the new wave of innovation at BIOEurope Spring—the event connecting the global life science community. The twentieth annual BIO-Europe Spring® partnering conference will be taking place March 23-25, 2026, in Lisbon, Portugal. Building relationships is an essential part
REGISTRATION
https://informaconnect.com/ bioeurope-spring/
Save up to €1,300 on your registration
Complete your registration by Friday, February 6
of any successful business partnership. BIO-Europe Spring brings together over 3,700 leading executives from around the world, hosting more than 20,000 partnering meetings between biotech companies, startups and academia, pharma companies and forward-thinking investors. Along with workshops and panels, company presentations, and an active exhibition, the variety of networking opportunities make this event an unrivalled forum for companies across the biotech value chain to meet and do business.
Together with the Biotechnology Innovation Organization (BIO), EBD Group is thrilled to welcome you back to this “must-attend” springtime partnering event – where you can both reconnect and discover.


23–25 March, 2026
Lisbon
Portugal

GREETING BIOEurope Spring is pinning Lisbon to the biotech map in 2026, uniting delegates from across the globe to take part in three full days of networking and partnership opportunities with up-andcoming companies.
Portugal's vibrant capital has emerged as one of Europe's most dynamic biotech ecosystems, where cutting-edge science meets entrepreneurial spirit against the backdrop of one of the world's most beautiful cities. Next March, BIO-Europe Spring 2026 brings you to the heart of this transformation.
Over the years EBD Group has redefined how the biopharma community connects, collaborates, and creates opportunities. Join us in Lisbon, March 23–25, 2026, to discover the latest industry insights, rekindle old connections and create new ones through one-to-one partnering meetings and dedicated networking activities. In 2026, the networking receptions will be hosted in some of Lisbon’s most iconic venues, ensuring unforgettable opportunities to build meaningful connections.
Set sail for Lisbon with the new wave of innovation.
Claire Macht EBD Group
by
Spring
BIO-Europe Spring brings together over 3,700 leading executives from around the world, hosting more than 20,000 partnering meetings between biotech companies, startups and academia with pharma companies and forward-thinking investors.
Register before February 6, 2026 and save up to €1,300!



PHARMACONGRESS & PHARMATECHNICA EXPO – bringing together authorities and industry – delegates benefit from users #sharing challenges and solutions in practice in 8 conferences and from networking.
On 24/25 March 2026, GMP PharmaCongress & GMP PharmaTechnica Expo in the Wiesbaden RheinMain CongressCenter will once again become Europe’s platform for pharmaceutical and biopharmaceutical production, quality, and innovation. Industry and regulatory experts will meet to discuss latest trends, technologies, and regulatory developments shaping the future of pharma manufacturing.
The congress programme features 8 parallel conferences with renowned
speakers presenting best practices, real-life solutions and pioneering projects. Participants can expect exclusive insights into automation, digital transformation, AI, aseptic manufacturing, the design, construction, qualification, and operation of GMP-compliant pharmaceutical facilities, challenges in ATMP manufacturing, regulatory requirements for pre-fillable syringes and for pre-sterilised packaging material and single-usesystems as well as into modern microbiological methods and their validation.

24/25 March 2026 Wiesbaden, Germany
Running alongside the congress, the PharmaTechnica Expo will showcase state-of-the-art equipment, innovative systems, and forward-thinking services. Congress delegates and expo visitors can experience live demonstrations and explore how intelligent technologies can improve efficiency and drive productivity while maintaining GMP compliance.
Another highlight of the event is the presentation of the prestigious Professor Wallhäußer Innovation Award, for which you can still submit your project. The award honours innovations in GMP and pharmaceutical technology.
With its unique mix of knowledge transfer, innovation, and networking, PharmaCongress and PharmaTechnica 2026 once again positions itself as Europe’s premier platform for GMP professionals seeking practical solutions and future-oriented ideas aiming to shape the future in pharmaceutical manufacturing.

GREETING We look forward to meeting you on 24/25 March 2026 at PharmaCongress & PharmaTechnica Expo in the RheinMain CongressCenter Wiesbaden. Book your one- or twodays ticket and benefit from the ECA Foundation’s special community celebration offer: get 3 tickets for the price of 1 and a free ECA mem-
bership for all three participants on top (until 31 December 2025). So join us and the around 100 expert speakers from authorities, industry and service providers who will share with you their wealth of experience in the 8 conferences and the expo.
Axel H. Schroeder Operations Director, Concept Heidelberg
Content
› 8 parallel Conference Tracks
› Live Demonstrations
› Prof Wallhäußer
Innovation Award Ceremony
› Expo with 120 Exhibitors
› Social Event
www.pharma-congress.com


24/25 MARCH 2026
WIESBADEN, RHEINMAIN CONGRESSCENTER
8 | 100 | 120 Conferences Exhibitors Speakers
Join the more than 100 speakers #sharing challenges and solutions in practice at the GMP PharmaCongress in the RheinMain CongressCenter in Wiesbaden. In 8 conference tracks you will benefit from case studies and lectures on production and quality assurance topics, also taking up digitalisation, automation and AI. Book your one- or two-days ticket to create your individual agenda from all conferences, and get to know and discuss latest products and technology developments with the leading European suppliers – in the parallel PharmaTechnica Expo with close to 120 exhibitors. To learn more, scan the QR code or visit pharma-congress.com.


BIO:CAP is the premier Life-Science and AI Investival in Berlin. Combining curated networking, innovative keynotes, and hands-on sessions by day with festival-style social events in the evening, it connects startups, investors, industry and research globally.
bio:cap 2026 brings together the global LifeScience and AI ecosystem at the City Cube on the Berlin exhibition grounds. The event blends the focus of an investor conference with the energy of a festival: curated matchmaking, inspiring keynotes, deep-dive sessions, and interactive panels highlight innovations in biotech, diagnostics, and AI-driven health solutions. Networking is at the heart of bio:cap, with dedicated zones for founder-investor 1:1s, a Capital Zone for VCs and

GREETING It’s a special moment to open the doors to an event built with one clear mission: bringing together the people shaping the future of Life Sciences and AI.
With bio:cap, we’re creating a space where ideas move fast, conversations spark opportunities, and innovation becomes tangible. This premiere is more than a new confer-
family offices, and informal lounge areas for spontaneous conversations. Attendees also experience Berlin’s unique vibe: move between idea-sparking installations, discover partner innovations at their booths, or grab snacks and drinks at a Berlin-style Späti.
Berlin’s dense network of leading universities, research institutions, and biotech startups provides the perfect environment for innovation and collaboration, making it an ideal host city for bio:cap. The event is
ence format – it’s an invitation to think boldly, connect across disciplines, and accelerate solutions the world needs.
And there’s no better place to launch an Investival than Berlin – a city where science, creativity, political leadership, and big ideas meet.
Whether you’re here as a founder, investor, researcher, or ecosystem partner, I’m excited for the collaborations and momentum that will grow over these three days.
Join us for the ideas – stay for the energy only Berlin can deliver.
Lara Formichella
Project Lead bio:cap

9–11 June, 2026
City Cube, Berlin Exhibition Grounds, Germany
shaped in close partnership with the Charité, BIH and HPI, supported by leading figures such as Prof. Heyo Kroemer (CEO, Charité), Prof. Eicke Latz (immunologist and life-science investor), and Prof. Ariel Stern (HPI), a leading voice at the intersection of digital health, economics, and policy.
On the second evening, the official bio:cap Investival Party turns a hand-picked Berlin venue into a hub for vibrant discussions and new collaborations.
By combining strategic networking, cutting-edge science, and Berlin’s dynamic lifestyle, bio:cap showcases the future of Life Sciences and AI, making it a must-attend event for startups, investors, researchers, and policymakers worldwide.
International Life-Science & AI Investival
– a combination of investor forum, innovation platform, and networking festival TARGET AUDIENCE
Start-ups & scale-ups, biotech & pharma companies, research institutions, IT & AI providers, investors, policymakers HIGHLIGHTS
› Curated partnering & matchmaking
› Keynotes and deep-dive sessions on biotech, diagnostics, and AI
› Startup pitches and reverse pitches from major funds
› Festival vibes: networking lounges, Berlin-style Späti, bio:cap Investival Party
www.biocap-europe.com



SLAS The SLAS International Conference & Exhibition is the premier event for laboratory innovation, cutting-edge life sciences research and making critical connections to transform research.
SLAS2026, 7-11 February 2026, in Boston, MA (USA) is where connections are made between scientists, researchers and technology providers across the globe.
Whether that’s a connection between colleagues, a speaker and an audience member, a student and a mentor, an exhibitor and booth visitor, a start-up company CEO and an investor, or a hiring manager and a new employee – SLAS2026 unites scientists and technology providers from around the world with a common goal of transforming research.
This year we’ve stepped it up to include add-on access to the best-in-class part-
nering from PartneringONE. SLAS2026 is the perfect place for investors and VCs to meet with 17 start-up companies on Innovation AveNEW as well as exhibitors with new products and non-exhibiting startups. PartneringONE packages include access to 1:1 partnering pods, a partnering lounge, and a post-event report. Select Innovation AveNEW companies will also conduct fast pitch sessions in the Ignite Theater.
Connections are also made during SLAS's 17 Topical Interest Group discussion sessions, and countless opportunities for “aha!” moments throughout this year’s

7-11 February, 2026 MCEC - Boston
nine scientific tracks and exhibitor-led Solutions Spotlight presentations.
Our NexusXp: The Connected Lab pavilion will showcase automation integration scenarios, flash talks and panel discussions to help you make physical connections in your own lab.
For students and early-career professionals, SLAS has a host of opportunities: a Networking Power Hour, career consulting and mentoring sessions, and Student Poster Award recognition. Poster presentation sessions are an ideal way to investigate the work being done globally, compare notes with authors who may become your next collaborator.
Forge your connections at SLAS2026. Visit: https://www.slas.org/2026 and register by December 8 for early-bird discounts!
Registration https://www.slas.org/2026
400 exhibitors, 7000 attendees, 150 speakers

GREETING SLAS is thrilled to be back in Boston, serving as the catalyst for science and lab innovation in 2026. We believe in the power of the SLAS community to solve common challenges, feed their curiosity, engage as collaborators, mentors, and teams, and work
toward a stronger global scientific force for good. Science doesn’t progress in a vacuum, and we are proud to help forge the connections that transform research.
See you there!
Jill Hronek SLAS Director, Marketing & Communications
Programme Highlights
SLAS provides an energetic environment for exploring the latest lab automation innovation and scientific applications across a broad range of life sciences research. With participants from more than 40 countries, SLAS2026 offers a world of innovation under one roof.